BTK and COVID-19: Moreover, a systematic review of outcomes from studies investigating the use of BTK inhibitors in patients with COVID-19 identified trends for decreased oxygenation requirements and/or decreased hospitalization and the need for care, but noted that these results were based on a small number of studies of mostly small sample sizes, and as such, should be interpreted with caution.24